P. Feuillan

发表

Frequent occurrence of asplenism and cholelithiasis in patients with autoimmune polyglandular disease type I.

G. Chrousos, T. Fleisher, F. Cassorla, 1991, The American journal of medicine.

Long-Term Testolactone Therapy for Precocious Puberty in Girls With the McCune-Albright Syndrome

G. Cutler, P. Feuillan, Janet Jones, 1994 .

Characterization of gsp-mediated growth hormone excess in the context of McCune-Albright syndrome.

S. Wientroub, D. Leroith, M. Collins, 2002, The Journal of clinical endocrinology and metabolism.

Growth hormone plus childhood low-dose estrogen in Turner's syndrome.

D. Cao, J. Ross, C. Quigley, 2011, The New England journal of medicine.

Letrozole treatment of precocious puberty in girls with the McCune-Albright syndrome: a pilot study.

T. Shawker, K. Calis, M. Collins, 2007, The Journal of clinical endocrinology and metabolism.

Lack of efficacy of fadrozole in treating precocious puberty in girls with the McCune-Albright syndrome.

S. B. Nunez, K. Calis, G. Cutler, 2003, The Journal of clinical endocrinology and metabolism.

Increased final height in precocious puberty after long-term treatment with LHRH agonists: the National Institutes of Health experience.

K. Klein, G. Cutler, P. Feuillan, 2001, The Journal of clinical endocrinology and metabolism.

Growth hormone hypersecretion in a girl with McCune-Albright syndrome: comparison with controls and response to a dose of long-acting somatostatin analog.

J. Ross, P. Feuillan, J. Jones, 1995, The Journal of clinical endocrinology and metabolism.

Psychosocial Development in Adolescents with Turner Syndrome

J. Ross, H. Kushner, E. McCauley, 2001, Journal of developmental and behavioral pediatrics : JDBP.

Reproductive axis after discontinuation of gonadotropin-releasing hormone analog treatment of girls with precocious puberty: long term follow-up comparing girls with hypothalamic hamartoma to those with idiopathic precocious puberty.

G. Cutler, P. Feuillan, K. Barnes, 1999, The Journal of clinical endocrinology and metabolism.

Severe endocrine and nonendocrine manifestations of the McCune-Albright syndrome associated with activating mutations of stimulatory G protein GS.

M. Merino, L. Weinstein, A. Shenker, 1993, The Journal of pediatrics.

Resumption of puberty after long term luteinizing hormone-releasing hormone agonist treatment of central precocious puberty.

O. Pescovitz, G. Cutler, P. Feuillan, 1988, The Journal of clinical endocrinology and metabolism.

Evidence for Decreased Growth Hormone in Patients with Hypothalamic Hamartoma due to Pallister-Hail Syndrome

L. Biesecker, P. Feuillan, Gordon B. Cutler, Jr., 2001, Journal of pediatric endocrinology & metabolism : JPEM.

Boys with precocious puberty due to hypothalamic hamartoma: reproductive axis after discontinuation of gonadotropin-releasing hormone analog therapy.

G. Cutler, P. Feuillan, K. Barnes, 2000, The Journal of clinical endocrinology and metabolism.

A novel testis-stimulating factor in familial male precocious puberty.

J. Doppman, G. Cutler, P. Feuillan, 1991, The New England journal of medicine.

Onset, Progression, and Plateau of Skeletal Lesions in Fibrous Dysplasia and the Relationship to Functional Outcome

A. Leet, Clara C. Chen, M. Collins, 2007, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Angiotensin II binding sites in the rat fetus: characterization of receptor subtypes and interaction with guanyl nucleotides

G. Aguilera, P. Feuillan, M. Millan, 1993, Regulatory Peptides.

Use of aromatase inhibitors in precocious puberty.

D. Merke, G. Cutler, P. Feuillan, 1999, Endocrine-related cancer.

Lipid abnormalities in Turner syndrome.

J. Ross, H. Kushner, G. Cutler, 1995, The Journal of pediatrics.

Normal bone density of the wrist and spine and increased wrist fractures in girls with Turner's syndrome.

F. Cassorla, J. Ross, G. Cutler, 1991, The Journal of clinical endocrinology and metabolism.

Effects of suramin on the function and structure of the adrenal cortex in the cynomolgus monkey.

G. Chrousos, C. Stein, P. Feuillan, 1987, The Journal of clinical endocrinology and metabolism.

Pubertal growth: physiology and pathophysiology.

F. Cassorla, J. Ross, O. Pescovitz, 1986, Recent progress in hormone research.

Dissociation between cortisol and adrenal androgen secretion in patients receiving alternate day prednisone therapy.

S. Pillemer, G. Chrousos, G. Tsokos, 1987, The Journal of clinical endocrinology and metabolism.

The role of type 1 and type 2 5'-deiodinase in the pathophysiology of the 3,5,3'-triiodothyronine toxicosis of McCune-Albright syndrome.

T. Shawker, F. Celi, M. Collins, 2008, The Journal of clinical endocrinology and metabolism.

Visualization of fibrous dysplasia during somatostatin receptor scintigraphy.

F. Czerwiec, P. Feuillan, C. C. Chen, 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Thyroid abnormalities in the McCune-Albright syndrome: ultrasonography and hormonal studies.

T. Shawker, P. Feuillan, B. Nisula, 1990, The Journal of clinical endocrinology and metabolism.

Developmental changes in angiotensin II receptor subtypes and AT1 receptor mRNA in rat kidney.

G. Aguilera, S. Kapur, P. Feuillan, 1994, Kidney international.

Characterization and distribution of angiotensin-II receptors in the primate fetus.

P. Feuillan, G. Aguilera, M. Millan, 1990, The Journal of clinical endocrinology and metabolism.

The hypothalamic-pituitary-adrenal axis in partial (late-onset) 21-hydroxylase deficiency.

G. Chrousos, S. Pang, P. Feuillan, 1988, The Journal of clinical endocrinology and metabolism.

Report from the workshop on Pallister-Hall syndrome and related phenotypes.

L. Biesecker, J. Graham, A. Verloes, 1996, American journal of medical genetics.

Ovarian Function in Girls with McCune-Albright Syndrome

T. Shawker, V. Padmanabhan, O. Pescovitz, 1986, Pediatric Research.

The effect of ketoconazole on steroidogenesis: I. Leydig cell enzyme activity in vitro.

J. Dunn, P. Feuillan, D. Loriaux, 1988, Research communications in chemical pathology and pharmacology.

The effect of ketoconazole on steroidogenesis. II. Adrenocortical enzyme activity in vitro.

J. Dunn, P. Feuillan, D. Loriaux, 1988, Research communications in chemical pathology and pharmacology.

Ketoconazole treatment of type 1 autoimmune polyglandular syndrome: effects on pituitary-adrenal axis.

G. Chrousos, P. Feuillan, G. Bright, 1986, The Journal of pediatrics.

Patients with Bardet-Biedl syndrome have hyperleptinemia suggestive of leptin resistance.

L. Biesecker, J. Johnston, J. Yanovski, 2011, The Journal of clinical endocrinology and metabolism.

LONG‐TERM OUTCOME OF OPTIC NERVE ENCASEMENT AND OPTIC NERVE DECOMPRESSION IN PATIENTS WITH FIBROUS DYSPLASIA: RISK FACTORS FOR BLINDNESS AND SAFETY OF OBSERVATION

Janice S. Lee, J. Butman, E. FitzGibbon, 2006, Neurosurgery.

McCune-Albright syndrome: the patterns of scintigraphic abnormalities.

P. Feuillan, E. Molina, T. Simon, 1990, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Use of estrogen in young girls with Turner syndrome

J. Ross, H. Kushner, D. Roeltgen, 2000, Neurology.

Absence of growth hormone effects on cognitive function in girls with Turner syndrome.

J. Ross, H. Kushner, D. Roeltgen, 1997, The Journal of clinical endocrinology and metabolism.

Self-concept and behavior in adolescent girls with Turner syndrome: potential estrogen effects.

J. Ross, H. Kushner, D. Roeltgen, 1996, The Journal of clinical endocrinology and metabolism.

Effects of estrogen on nonverbal processing speed and motor function in girls with Turner's syndrome.

J. Ross, H. Kushner, D. Roeltgen, 1998, The Journal of clinical endocrinology and metabolism.

Androgen-responsive aspects of cognition in girls with Turner syndrome.

G. Stefanatos, J. Ross, C. Bondy, 2003, The Journal of clinical endocrinology and metabolism.

Alternate day prednisone therapy in congenital adrenal hyperplasia: adrenal androgen suppression and normal growth.

G. Chrousos, P. Feuillan, B. Linder, 1989, The Journal of clinical endocrinology and metabolism.

Regulation of aldosterone in the 7-day-old rat.

G. Aguilera, P. Feuillan, Greti Aguilera, 1996, Endocrinology.

Follow-up of children and young adults after GnRH-agonist therapy for central precocious puberty

G. Cutler, P. Feuillan, J. Jones, 2001, Journal of Endocrinological Investigation.

Luteinizing hormone-releasing hormone (LHRH)-independent precocious puberty unresponsive to LHRH agonist therapy in two girls lacking features of the McCune-Albright syndrome.

G. Cutler, P. Feuillan, J. Jones, 1991, The Journal of clinical endocrinology and metabolism.

Treatment of precocious puberty in the McCune-Albright syndrome with the aromatase inhibitor testolactone.

J. Malley, T. Shawker, A. Dwyer, 1986, The New England journal of medicine.

Long-term testolactone therapy for precocious puberty in girls with the McCune-Albright syndrome.

G. Cutler, P. Feuillan, Janet Jones, 1993, The Journal of clinical endocrinology and metabolism.

Testolactone treatment of precocious puberty in McCune-Albright syndrome

O. Pescovitz, P. Feuillan, F. Comite, 2008 .

Hypothalamic Hamartomas and Seizures: Distinct Natural History of Isolated and Pallister‐Hall Syndrome Cases

L. Biesecker, W. Theodore, N. Patronas, 2005, Epilepsia.

Adrenal steroid responses to continuous intravenous adrenocorticotropin infusion compared to bolus injection in normal volunteers.

G. Chrousos, D. Rodbard, G. Cutler, 1986, The Journal of clinical endocrinology and metabolism.

Letter to the Editor Further Study of the Therapy for Fibrous Dysplasia Is Necessary

F. Czerwiec, A. Shenker, P. Feuillan, 1997, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

ACCELERATION OF LINEAR GROWTH AFTER REPEATED DOSES OF GROWTH HORMONE-RELEASING FACTOR (GRF)

F. Cassorla, J. Ross, G. Merriam, 1984, Pediatric Research.

Testolactone treatment of precocious puberty in McCune-Albright syndrome.

T. Shawker, O. Pescovitz, G. Cutler, 1985, Acta Endocrinologica.

Patients with Bardet-Biedl syndrome have hyperleptinemia suggestive of leptin resistance.

Julie C. Sapp, L. Biesecker, J. Johnston, 2011, The Journal of clinical endocrinology and metabolism.